Benzinga·Mar 2·Vandana SinghRallybio Surges 29% on $505M Merger with Candid TherapeuticsRallybio soars as merger with $505M-backed Candid Therapeutics creates combined biotech with $700M cash runway through 2030. RLYBbiotechclinical trials
Benzinga··Vandana Singh